Managers / Q1 2026
SHARPEPOINT LLC
CIK 0002046822 · 5090 N 40TH ST SUITE 200, PHOENIX, AZ, 85018 · 4809993033
Summary
Sharpepoint LLC reported $168M in U.S.-listed holdings across 86 positions for Q1 2026.
Its largest position, Ishares Tr, represents 5.2% of the portfolio.
Compared with Q4 2025, the fund opened 7 new positions and exited 5.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 55.6% · $93M
- ETP · 29.7% · $50M
- ADR · 5.1% · $8M
- Other · 3.8% · $6M
- REIT · 3.0% · $5M
- Other · 2.8% · $5M
Quarter-over-Quarter Changes full breakdown →
vs Q4 2025 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| SEAGATE TECHNOLOGY HLDNGS PL | NEW | +10.4K | 10.4K | +$4M | $4M |
| WISDOMTREE TR | NEW | +25.4K | 25.4K | +$4M | $4M |
| TPDSOMNIGROUP INTERNATIONAL INC | NEW | +5.0K | 5.0K | +$366,791 | $366,791 |
| OLNOLIN CORP | NEW | +7.5K | 7.5K | +$223,213 | $223,213 |
| MODMODINE MFG CO | NEW | +1.0K | 1.0K | +$218,010 | $218,010 |
| COSTCOSTCO WHOLESALE CORPORATION | NEW | +211 | 211 | +$210,247 | $210,247 |
| DFTXDEFINIUM THERAPEUTICS INC | NEW | +10.0K | 10.0K | +$189,000 | $189,000 |
| ENTREPRENEURSHARES SERIES TR | ADDED | +25.2K | 38.8K | +$381,523 | $654,521 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q1 2026
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $168M | 86 | May 5, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $167M | 84 | Feb 11, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $111M | 42 | Nov 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $97M | 43 | Aug 11, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $114M | 77 | Apr 30, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $111M | 73 | Feb 13, 2025 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.